- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-TXNRD1
TXNRD1 Monoclonal Antibody for WB, IHC, IF/ICC, Indirect ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain, rat, souris
Applications
WB, IHC, IF/ICC, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
1B10C4
N° de cat : 67728-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
67728-1-PBS cible TXNRD1 dans les applications de WB, IHC, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris |
| Hôte / Isotype | Mouse / IgG1 |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | TXNRD1 Protéine recombinante Ag30071 |
| Nom complet | thioredoxin reductase 1 |
| Masse moléculaire calculée | 55 kDa |
| Poids moléculaire observé | 50-70 kDa |
| Numéro d’acquisition GenBank | BC018122 |
| Symbole du gène | TXNRD1 |
| Identification du gène (NCBI) | 7296 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
Thioredoxin reductase-1 (TXNRD1) is uniquely capable of utilizing electrons from NADPH to recover the reduced state of TRX1. Interestingly, TXNRD1 is upregulated in many human malignancies and promotes cancer progression, and attenuation of TXNRD1 levels effectively suppresses the growth of tumor cells (PMID: 31384178). TXNRD1 is also upregulated in many human malignancies and functions as a prognostic factor for many tumors, such as oral squamous cell carcinomas, lung cancer, breast cancer, and astrocytomas. TXNRD1 protein levels were analyzed by inmmunoblotting. Bands of ~55 kDa for TXNRD1 were observed. IHC analysis suggested TXNRD1 was mainly located in the cytoplasm. (PMID: 28536696, PMID: 20584310)









